• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Idelalisib-rituximab induces durable remissions in TP53 disrupted B-PLL but results in significant toxicity: updated results of the UK-wide compassionate use programme.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Eyre, T
    Fox, C
    Boden, A
    Bloor, Adrian
    Dungawalla, M
    Shankara, P
    Went, R
    Schuh, A
    Affiliation
    Department of Haematology, Oxford University Hospitals NHS Trust, Churchill Hospital, Oxford, UK
    Issue Date
    2018-02-22
    
    Metadata
    Show full item record
    Citation
    Idelalisib-rituximab induces durable remissions in TP53 disrupted B-PLL but results in significant toxicity: updated results of the UK-wide compassionate use programme. 2018, Br J Haematol
    Journal
    British Journal of Haematology
    URI
    http://hdl.handle.net/10541/620921
    DOI
    10.1111/bjh.15151
    PubMed ID
    29468637
    Type
    Article
    Language
    en
    ISSN
    1365-2141
    ae974a485f413a2113503eed53cd6c53
    10.1111/bjh.15151
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Idelalisib-Rituximab induces clinical remissions in patients with TP53 disrupted B cell prolymphocytic leukaemia.
    • Authors: Eyre TA, Fox CP, Shankara P, Went R, Schuh AH
    • Issue date: 2017 May
    • Idelalisib-related pneumonitis.
    • Authors: Haustraete E, Obert J, Diab S, Abbes S, Zini JM, Valade S, Lerolle N, Albin N, Arnulf B, Bouaziz JD, Hussenet C, Tazi A, Bergeron A
    • Issue date: 2016 Apr
    • Effective upfront treatment with low-dose ibrutinib for a patient with B cell prolymphocytic leukemia.
    • Authors: Oka S, Ono K, Nohgawa M
    • Issue date: 2020 Oct
    • B and T cell prolymphocytic leukaemia.
    • Authors: Cross M, Dearden C
    • Issue date: 2019 Sep
    • Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review.
    • Authors: Xing L, He Q, Xie L, Wang H, Li Z
    • Issue date: 2022 May 1
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.